These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3475036)

  • 21. Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections.
    Federspil PJ; Lind A; Tiesler E; Schmidt B
    Infection; 1986; 14 Suppl 3():S211-2. PubMed ID: 3463545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of antibiotics into respiratory secretions.
    Pennington JE
    Rev Infect Dis; 1981; 3(1):67-73. PubMed ID: 7013001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enoxacin pharmacokinetics and efficacy in CF-1 mice.
    Chartrand SA; Scribner RK; Marks MI; Dice J
    J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia.
    Klekner A; Bagyi K; Bognar L; Gaspar A; Andrasi M; Szabo J
    J Clin Microbiol; 2006 Sep; 44(9):3418-21. PubMed ID: 16954290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.
    Kemmerich B; Borner K; Pennington JE
    Antimicrob Agents Chemother; 1987 Mar; 31(3):417-20. PubMed ID: 3495234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enoxacin in the treatment of lower respiratory tract infections.
    Philip-Joet F; Nourrit J; Frances Y; Arnaud A
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():125-9. PubMed ID: 3258863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI; Dabbs DJ; Spencer RC
    J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
    Duncan IB; Skulnick M; Marshall PW
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():1-6. PubMed ID: 6438046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Antimicrob Agents Chemother; 1987 Jan; 31(1):102-3. PubMed ID: 3471177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
    Charton M; Timbal Y
    Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetration of ampicillin into human bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Kafe H; Morel C
    Infection; 1979; 7 Suppl 5():S463-4. PubMed ID: 511358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of ciprofloxacin into bronchial secretions.
    Bergogne-Bérézin E; Berthelot G; Even P; Stern M; Reynaud P
    Eur J Clin Microbiol; 1986 Apr; 5(2):197-200. PubMed ID: 2941280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Sedman A; Rowland M
    Clin Pharmacol Ther; 1987 Jul; 42(1):33-41. PubMed ID: 3474093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The penetration of ofloxacin into bronchial secretions.
    Symonds J; Javaid A; Bone M; Turner A
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():91-5. PubMed ID: 3182469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enoxacin in lower respiratory tract infections.
    Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
    J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.